FdaApplication
ANDA 206873
Identifiers
- fda_app_no: ANDA206873
Properties
| Property | Value |
|---|---|
| applicant_name | SYNTHON BV |
| application_type | ANDA |
| approval_date | 2024-09-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLATIRAMER ACETATE | GLATIRAMER ACETATE | 40MG/ML | INJECTABLE;SUBCUTANEOUS |
1 product